Kyle Carver's Insider Trades & SAST Disclosures

Kyle Carver's most recent trade in Evommune Inc. was a trade of 1,000 Common Stock done at an average price of $13.3 . Disclosure was reported to the exchange on July 8, 2026.

Share

Note

This is a custom search result for pattern Kyle Carver.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 13.26 per share.	08 Jul 2026	1,000	60,335	-	13.3	13,260	Common Stock
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 22.84 per share.	28 May 2026	18,175	59,335	-	22.8	415,117	Common Stock
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.99 per share.	28 May 2026	15,000	77,510	-	3.0	44,850	Common Stock
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer		28 May 2026	15,000	96,731	-		-	Employee Stock Option (Right to Buy)
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer		16 Apr 2026	98,946	98,946	-		-	Employee Stock Option (Right to Buy)
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.84 per share.	09 Dec 2025	13,290	62,510	-	17.8	237,094	Common Stock
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer		07 Nov 2025	25,000	0	-		-	Series B Preferred Stock
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer		07 Nov 2025	3,175	75,800	-		-	Common Stock
Evommune Inc 10-year low	Mr. Kyle Carver, C.P.A.,M.B.A.	Chief Financial Officer		05 Nov 2025	279,408	279,408	-		-	Employee Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades